Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Alge, Joseph L ^a   Karakala, Nithin ^a   Neely, Benjamin A ^a   Janech, Michael G ^a   Velez, Juan Carlos Q ^a   Arthur, John M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CREATININE URINE LEVEL; CRITICALLY ILL PATIENT; DEATH; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART SURGERY; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SENSITIVITY AND SPECIFICITY; URINALYSIS; ACUTE KIDNEY INJURY; AGED; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; TRENDS; URINE; VERY ELDERLY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSINOGEN; BIOMARKERS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 84876144535     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12612     Document Type: Article

References (33)

1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, . Acute Dialysis Quality Initiative workgroup Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-12. 10.1186/cc2872, 522841, 15312219, Acute Dialysis Quality Initiative workgroup.
2. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, . Acute Kidney Injury Network Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245, Acute Kidney Injury Network.
3. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370. 10.1681/ASN.2004090740, 16177006.
4. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008, 73:538-546. 10.1038/sj.ki.5002743, 18160961.
5. Bagshaw SM, George C, Bellomo R, . ANZICS Database Management Committe A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008, 23:1569-1574. 10.1093/ndt/gfn009, 18281319, ANZICS Database Management Committe.
6. Stewart IJ, Tilley MA, Cotant CL, Aden JK, Gisler C, Kwan HK, McCorcle J, Renz EM, Chung KK. Association of AKI with adverse outcomes in burned military casualties. Clin J Am Soc Nephrol 2012, 7:199-206. 10.2215/CJN.04420511, 22156751.
7. Zhou J, Yang L, Zhang K, Liu Y, Fu P. Risk factors for the prognosis of acute kidney injury under the Acute Kidney Injury Network definition: a retrospective, multicenter study in critically ill patients. Nephrology (Carlton) 2012, 17:330-337.
8. Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009, 35:1692-1702. 10.1007/s00134-009-1530-4, 19547955.
9. Murray PT, Devarajan P, Levey AS, Eckardt KU, Bonventre JV, Lombardi R, Herget-Rosenthal S, Levin A. A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol 2008, 3:864-868. 10.2215/CJN.04851107, 18287251.
10. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2012, 2(Suppl):1-138. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group.
11. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002, 62:237-244. 10.1046/j.1523-1755.2002.00433.x, 12081583.
12. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008, 73:863-869. 10.1038/sj.ki.5002715, 2586909, 18059454.
13. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14:2534-2543. 10.1097/01.ASN.0000088027.54400.C6, 14514731.
14. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238. 10.1016/S0140-6736(05)74811-X, 15811456.
15. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004, 43:405-414. 10.1053/j.ajkd.2003.10.040, 14981598.
16. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006, 70:199-203. 10.1038/sj.ki.5001527, 16710348.
17. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66:1115-1122. 10.1111/j.1523-1755.2004.00861.x, 15327406.
18. Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008, 74:1059-1069. 10.1038/ki.2008.341, 2745082, 18650797.
19. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010, 5:2154-2165. 10.2215/CJN.00740110, 2994075, 20798258.
20. Koyner JL, Garg AX, Coca SG, Sint K, Thiessen-Philbrook H, Patel UD, Shlipak MG, Parikh CR, . for the TRIBE-AKI Consortium Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 2012, 23:905-914. 10.1681/ASN.2011090907, 3338298, 22383693, for the TRIBE-AKI Consortium.
21. Hall IE, Coca SG, Perazella MA, Eko UU, Luciano RL, Peter PR, Han WK, Parikh CR. Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis. Clin J Am Soc Nephrol 2011, 6:2740-2749. 10.2215/CJN.04960511, 3255362, 22034509.
22. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM, . SAKInet Investigators Urinary angiotensinogen and risk of severe AKI. Clin J Am Soc Nephrol 2013, 8:184-193. 10.2215/CJN.06280612, 23143504, SAKInet Investigators.
23. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002, 62:2223-2229. 10.1046/j.1523-1755.2002.00683.x, 12427149.
24. Pepin MN, Bouchard J, Legault L, Ethier J. Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am J Kidney Dis 2007, 50:566-573. 10.1053/j.ajkd.2007.07.001, 17900456.
25. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states. Nephron Clin Pract 2010, 114:c145-50. 10.1159/000254387, 19887835.
26. Bellomo R, Bagshaw S, Langenberg C, Ronco C. Pre-renal azotemia: a flawed paradigm in critically ill septic patients?. Contrib Nephrol 2007, 156:1-9.
27. Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein CL, Walker RJ, Endre ZH. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012, 81:1254-1262. 10.1038/ki.2012.23, 3365288, 22418979.
28. Allred AJ, Chappell MC, Ferrario CM, Diz DI. Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol 2000, 279:F636-645.
29. da Silveira KD, Pompermayer Bosco KS, Diniz LR, Carmona AK, Cassali GD, Bruna-Romero O, de Sousa LP, Teixeira MM, Santos RA, Simoes e Silva AC, Ribeiro Vieira MA. ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci (Lond) 2010, 119:385-394.
30. Barrilli A, Molinas S, Petrini G, Menacho M, Elias MM. Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function. Mol Cell Biochem 2004, 260:161-170.
31. Molinas SM, Cortes-Gonzalez C, Gonzalez-Bobadilla Y, Monasterolo LA, Cruz C, Elias MM, Bobadilla NA, Trumper L. Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury. Nephron Exp Nephrol 2009, 112:e10-19. 10.1159/000210574, 19342869.
32. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 2002, 61:579-585. 10.1046/j.1523-1755.2002.00155.x, 2575665, 11849399.
33. Kim SM, Jang HR, Lee YJ, Lee JE, Huh WS, Kim DJ, Oh HY, Kim YG. Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease. Clin Nephrol 2011, 76:117-123.